Skip to main content
Clinical Trials/NCT03629626
NCT03629626
Completed
Not Applicable

A Prospective, Randomized Trial Comparing ERAS and Conventional Protocol for Perioperative Care of Patients After Gynecological Surgery

Shandong University1 site in 1 country540 target enrollmentAugust 15, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gynecologic Disease
Sponsor
Shandong University
Enrollment
540
Locations
1
Primary Endpoint
Shorter Length Of Hospitalization (LOH)
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Enhanced recovery programs are composed of preoperative, intraoperative and postoperative strategies combined to form a multi-modal pathway. ERAS requires a multidisciplinary team of anesthetists, surgeons and nurses for successful implementation and realization of its advantages.The aim of this study is to compare outcomes of conventional perioperative care with those of an enhanced recovery after surgery (ERAS) perioperative care plan in women undergoing surgery for gynecologic cancer or suspected gynecologic disease.

Detailed Description

The study design is a two-arm, randomized, controlled trial. The control arm will consist of standard conventional perioperative care. The intervention arm will consist of a protocol-driven ERAS program. The investigators believe that this information will be very useful because although there is a national interest in creating ERAS protocols for gynecology, there currently is very little published on the subject. Investigators hypothesize that those patients randomized to the ERAS protocol will have shorter lengths of hospital stay and complications, without increasing readmission rates. The investigators would like to publish the investigators' results and protocol as a resource for other institutions to adopt.

Registry
clinicaltrials.gov
Start Date
August 15, 2018
End Date
December 31, 2021
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Shandong University
Responsible Party
Principal Investigator
Principal Investigator

Beihua Kong

Clinical Professor

Shandong University

Eligibility Criteria

Inclusion Criteria

  • Age \>18 and \<70 years old
  • Patients candidated for elective gynecological surgery for benign pathology
  • Patients with diagnosis of gynecological neoplasm and candidated for elective gynecological surgery
  • Signed consent form

Exclusion Criteria

  • Contraindication to loco-regional anaesthesia
  • Patients with ileus or subocclusive condition prior surgery
  • Coagulation disorders
  • Organ failure or severe disfunction (heart, renal, pulmonary, hepatic)
  • Uncontrolled hypertension (\>180/95)
  • Alcohol or drug abuser (current or previous)
  • Psychiatric condition or language barriers
  • Planned Intensive Care Recovery

Outcomes

Primary Outcomes

Shorter Length Of Hospitalization (LOH)

Time Frame: Up to 4 weeks after surgery

Total amount of days spent in hospital

Secondary Outcomes

  • Presence/Absence of nausea(At moment 0, 3, 6, 12 and 24 hours after surgery)
  • Readmission rates(Up to 21 days post surgery)
  • Time to flatus(Up to 4 weeks after surgery)
  • Presence/Absence of vomiting(At moment 0, 3, 6, 12 and 24 hours after surgery)
  • Foley catheter removal(From 1 to 14days post surgery)
  • Time to drink(Up to 4 weeks after surgery)
  • Time to eating(Up to 4 weeks after surgery)
  • Time to bowel movement(Up to 4 weeks after surgery)
  • Time to walking(Up to 4 weeks after surgery)
  • Postoperative complications(Up to 2 weeks after surgery)
  • Assessment of postoperative pain(At moment 24 hours after surgery)
  • Time to adjuvant treatment(60 days)

Study Sites (1)

Loading locations...

Similar Trials